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Abstract: Mitochondria play a crucial role in the cell fate; in particular, reducing the accumulation
of calcium in the mitochondrial matrix offers cardioprotection. This affect is achieved by a mild
depolarization of the mitochondrial membrane potential, which prevents the assembly and opening
of the mitochondrial permeability transition pore. For this reason, mitochondria are an attractive
target for pharmacological interventions that prevent ischaemia/reperfusion injury. Isosteviol
is a diterpenoid created from the acid hydrolysis of Stevia rebaudiana Bertoni (fam. Asteraceae)
glycosides that has shown protective effects against ischaemia/reperfusion injury, which are likely
mediated through the activation of mitochondrial adenosine tri-phosphate (ATP)-sensitive potassium
(mitoKATP) channels. Some triphenylphosphonium (triPP)-conjugated derivatives of isosteviol
have been developed, and to evaluate the possible pharmacological benefits that result from
these synthetic modifications, in this study, the mitochondriotropic properties of isosteviol and
several triPP-conjugates were investigated in rat cardiac mitochondria and in the rat heart cell line
H9c2. This study’s main findings highlight the ability of isosteviol to depolarize the mitochondrial
membrane potential and reduce calcium uptake by the mitochondria, which are typical functions
of mitochondrial potassium channel openings. Moreover, triPP-conjugated derivatives showed a
similar behavior to isosteviol but at lower concentrations, indicative of their improved uptake into the
mitochondrial matrix. Finally, the cardioprotective property of a selected triPP-conjugated derivative
was demonstrated in an in vivo model of acute myocardial infarct.
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1. Introduction
Mitochondria are an attractive target for pharmacological interventions that prevent
ischaemia/reperfusion (I/R) injuries. Mild depolarization of the mitochondrial membrane potential
reduces calcium uptake into the matrix and consequently prevents the assembly and opening of
the mitochondrial permeability transition pore (MPTP) [1]. This beneficial effect can result from
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the actions of multiple mitochondrial targets, such as kinase proteins, oxidative phosphorylation,
ion channels, and, in particular, potassium channels. According to the literature, diverse targets
are often involved in I/R injury protection, highlighting the complexity of the mitochondrial
mechanisms of cardioprotection; however, several types of potassium channels are localized on the
inner membrane of the mitochondria—for example, the calcium-dependent (mitoBK), ATP-sensitive
(mitoKATP), and recently voltage-operated (mitoKv7.4) channels have been considered exciting targets
for myocardial protection [1,2].
Isosteviol is a diterpenoid that is easily obtained by the acid hydrolysis of Stevia rebaudiana Bertoni
(fam. Asteraceae) glycosides, which are used for the production of non-caloric sugar substitutes [3].
Several studies have indicated that isosteviol possesses a variety of biological activities including
anti-hypertensive [4–6], anti-hyperglycemic [7], antioxidant, anti-inflammatory, and antitumor
effects [8,9]; in addition, it relieves I/R injury in rat brains [10] and in rodent hearts [11,12]. Xu and
colleagues demonstrated for the first time that isosteviol produces cardioprotective effects in rats
subjected to myocardial I/R injury. Indeed, isosteviol administered by intravenous (i..v.) for 10 min
before coronary occlusion protected the myocardium (decreased levels of lactate dehydrogenase
(LDH) and creatine kinase (CK)), reduced the myocardial infarct size, improved cardiac performance
(increased dp/dtmax, left ventricular systolic pressure (LVSP), and left ventricular developed pressure
(LVDevP)), and stabilized the electrophysiological properties of the heart (decreased occurrence of
ventricular tachycardia (VT) and ventricular fibrillation (VF)). The authors suggested that at least
some of the observed beneficial effects of isosteviol can be attributed to stimulation of the mitoKATP
channel [11]. Similar conclusions were reported by Xu et al., 2007 in an ex vivo model, and the
involvement of the mitoKATP channel was also hypothesized since a selective blocker of mitoKATP
channels, 5-hydroxydecanoic acid (5HD), antagonized its protective effects [12].
However, the involvement of alternative pathways is suggested in isosteviol-mediated myocardial
protection. Recently, Fan and colleagues observed that when isosteviol was administered alone, it failed
to produce any effects, whereas it increased the pinacidil-induced activation of sarcKATP channels
and potentiated the diazoxide-mediated oxidation of flavoproteins in mitochondria, suggesting the
engagement of mitoKATP channels [13,14].
The above literature suggests a key role for mitoKATP channels in the isosteviol cardioprotective
profile, which may be an exciting strategy for effectively driving diterpene into the mitochondria to
improve its pharmacokinetic profile and, consequently, its pharmacological effects.
Recently, isosteviol derivatives with carboxylic groups linked to the cationic
triphenylphosphonium (triPP) moiety by different linkers have been synthesized [15]. Conjugation to
the triPP moiety ensures high accumulation in the mitochondrial matrix due to the negative relative
voltage (about −180 mV), according to Nernst’s law. Indeed, there are many examples of the
triPP moiety being successfully used as a carrier for the preferential delivery of drugs into the
mitochondria [16]. Accordingly, triPP-conjugates of isosteviol exhibited pronounced antimitotic
effects in the sea urchin embryo model, indicative of mitochondrial uptake; moreover, a preliminary
structure–activity relationship study revealed the essential role of the triPP moiety for the isosteviol
effect since the chemical structure and the length of the linker had only limited impact on the biological
activity of these derivatives [15].
In this study, the mitochondriotropic properties of isosteviol and several triPP-conjugates
were investigated on rat cardiac mitochondria and on H9c2 cells in order to evaluate possible
pharmacological benefits resulting from such synthetic modifications.
2. Results
2.1. Mitochondriotropic Effects of Isosteviol
All isolated heart mitochondria had a membrane potential lower than −170 mV. The addition of
cumulatively increasing concentrations of isosteviol (0.1–30 µM) to the suspension of isolated heart
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mitochondria (1 mg/mL) caused a concentration-dependent ∆ψ depolarization. The vehicle was
almost completely ineffective at depolarizing the mitochondria (Figure 1A).
Moreover, the addition of calcium-free mitochondria into calcium-rich medium (100 µM) nearly
depleted this ion (108 ± 7 µM, n = 3) from the medium, indicating an avid uptake of calcium into
the mitochondrial matrix. The addition of isosteviol (3, 10, and 30 µM) to the medium caused a
concentration-dependent attenuation of calcium ion accumulation in the mitochondria (Figure 1B).
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Figure 1. Changes of mitochondrial membrane potential (A) and of calcium uptake into mitochondrial
matrix (B), potentiometrically measured, following addition of isosteviol at cardiac mitochondria
suspensions (1 mg/mL). Asterisks indicate significant differences vs. vehicle (* p < 0.05).
2.2. Mitochondriotropic Effects of Tripp-Conjugated Isosteviol Derivatives
Due to the inevitable interference of triPP-conjugated derivatives with the tetraPP-sensitive
electrode, the potentiometric approach was not suitable for the measurement of ∆ψ changes in
this treatment group. Therefore, a spectrofluorimetric method was applied, despite compromised
sensitivity of this method compared to that of the potentiometric approach.
As expected, the well-known uncoupling agent CCCP (0.01–1 µM) produced a marked and
concentration-dependent depolarizing effect, leading to the complete abolition of the ∆ψ value
(Figure S1).
Isosteviol influenced the ∆ψ only at high concentrations (300 µM), producing a fluorescence signal
up to 58 ± 7% of the signal obtained with rhodamine 123 alone (Table 1, Figure 2A–C).
In contrast, all tested triPP-conjugated compounds produced strong concentration-dependent
depolarizing effects.
Notably, the isosteviol derivatives, especially compounds 1 and 5, which have the longest
alkyl chains, showed an improved potency compared with that of the parent isosteviol (Table 1
and Figure 2A–C).
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When added to the medium, both the triPP-conjugated compounds 1 and 5 and tetraPP were 
immediately detected by the tetraPP-sensitive electrode. TetraPP accumulated according to Nernst’s 
law, indicative of an optimal potential value (about −180 mV). The introduction of cardiac 
mitochondria (1 mg/mL) to the suspension medium containing compound 1 or 5 caused a 
disappearance (downward deflection of the signal) of compounds 1 or 5 in the suspension medium, 
due to their uptake into the mitochondrial matrix (Figure 3B). Notably, both triPP-conjugated 
Figure 2. Changes of mitochondrial membrane potential (spectrofluorimetrically measured)
following addition at cardiac mitochondria suspension (0.5 mg/mL) (A,B). Increase (%) in the
rhodamine123-induced fluorescence after cumulative addition of isosteviol and compounds 1–5 (C).
Table 1. Potency (pEC50) and efficacy (Emax %) indices measured for isosteviol and its triPP-conjugated
derivatives (cmpds). Full = 100%.
Compounds pEC50 Emax (%)
Isosteviol 3.59 ± 0.074 58 ± 7
Cmpd 1 5.65 ± 1.67 Full
Cmpd 2 4.87 ± 0.65 Full
Cmpd 3 3.85 ± 0.090 82 ± 9
Cmpd 4 5.01 ± 0.095 Full
Cmpd 5 5.36 ± 0.060 Full
2.3. Uptake of Compounds 1 and 5 into the Mitochondrial Matrix
When added to the medium, both the triPP-conjugated compounds 1 and 5 and tetraPP
were immediately detected by the tetraPP-sensitive electrode. TetraPP accumulated according
to Nernst’s law, indicative of an optimal potential value (about −180 mV). The introduction of
cardiac mitochondria (1 mg/mL) to the suspension medium containing compound 1 or 5 caused
a disappearance (downward deflection of the signal) of compounds 1 or 5 in the suspension
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medium, due to their uptake into the mitochondrial matrix (Figure 3B). Notably, both triPP-conjugated
derivatives were completely taken into the matrix, to an even greater extent than tetraPP.
A representative experiment is shown in Figure 3A.
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Figure 4. Change in mitochondrial ∆ψ related to compound 5 and isosteviol cell treatments. H9c2 cells
were challenged with compound 5, isosteviol, and CCCP for 2.5 and 5 h, then the mitochondrial ∆ψ
was assessed by a cytofluorimetric technique. In panel (A), representative cytofluorimetric population
profiles are reported (2.5 h challenge). T e percentage of depolarized living cells after 2.5 and 5 h of
drug treatments are shown in panels (B,C), respectively. The percentage of depolarized dead cells
following 5 h (D) are also reported. Asterisks indicate significant differences vs. vehicle (* p < 0.05,
*** 0.001).
2.5. Cardioprotective Effects Observed with Isosteviol and Compound 5
In the SHA group, no significant evidence of damage was observed (data not shown),
whereas the acute infarct protocol led, in the VEHICLE group, to a marked myocardium damage
(Ai/ALV = 37 ± 2%). In the ISO 500 group, a significant reduction of the size of damaged areas was
observed (Ai/ALV = 21± 6%). In contrast, the cardiac protection was lost in the group ISO 5, which was
treated with a 100-fold lower dose of isosteviol (Ai/ALV = 39 ± 2%). Noteworthy, the pharmacological
treatment with compound 5 at the dose of 12.1 µg/Kg (equimolar to isosteviol 5 µg/Kg) produced a
significant reduction of the ischaemic areas (Ai/ALV = 26 ± 2%), which was similar to that observed
in the ISO 500 group (Figure 5).
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Figure 5. Morphometric quantification of ischaemia/reperfusion (I/R)-induced injury observed in
ventricular slices of rat hearts, after acute myocardial infarction in vivo, after treatment with VEHICLE,
ISO 500, ISO 5, or compound 5. Asterisks indicate significant differences vs. vehicle (* p < 0.05).
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3. Discussion
In conditions of cellular stress, mitochondria play a crucial role in cell fate since they can decide
when and how a cell will die; they are considered an especially key component in cardiomyocyte
dysfunction and cell death during I/R injury. It is widely accepted that reducing calcium overload
in the mitochondrial matrix is essential for cardioprotection. A reduction in calcium uptake can be
achieved by mild depolarization of the mitochondrial membrane. A modest depolarization prevents
the entry of high amounts of calcium into mitochondria [1], thereby reducing the probability that the
MPTP will form and open, and preserving cell viability during reperfusion. Thus, mitochondria are
considered a promising target for modern cardioprotective strategies.
In the recent years, compounds from the plant kingdom—particularly the flavonoid
class that contains interesting examples of natural compounds endowed with cardioprotective
mitochondria-targeting effects—have gained attention for their therapeutic potential [17,18].
Other plant-derived compounds, such as the well-known sweetener steviol glycoside
(rebaudiosides), have beneficial effects on the cardiovascular system [19]. In contrast to sugar,
rebaudiosides (specially the glycoside stevioside) demonstrate anti-hyperglycemic, insulinotropic,
and glucagonostatic effects [20,21]; moreover, isosteviol, a stevioside derivative, has protective effects
against I/R damage in the hearts and brains of rats [10–13].
Although its mechanism of action is not fully known, the cardioprotective effect is clear. In this
context, the first aim of this study was to demonstrate the role of mitochondria in the mechanism of
action of isosteviol.
Indeed, when isosteviol was cumulatively administered to a mitochondrial suspension,
concentration-dependent depolarization of the mitochondria occurred (Figure 1A), and this compound
was able to influence the movement of calcium ions, reducing the entry of calcium into the
mitochondrial matrix (Figure 1B).
Moreover, the use of novel drugs that are able to selectively accumulate in the mitochondria,
avoiding off-target effects on other cellular components, is an exciting, novel strategy for providing
protection against myocardial infarction. Accordingly, Murphy and colleagues [16] first developed the
chemical strategy of conjugating a triPP moiety to an antioxidant agent to drive it into the mitochondrial
matrix. This strategy has been used by other researchers to obtain selective mitochondrial delivery.
In particular, Kataev’s group synthesized isosteviol derivatives with anti-mitotic activity [15].
The second objective of this study was focused on the characterization of the mitochondriotropic
effects of the five novel isosteviol derivatives, which are derived from a diterpenoid skeleton
coupled to a triPP moiety by polyethylene glycol or polymethylene linkers of different lengths
(i.e., triPP-conjugates of isosteviol). To evaluate the depolarizing effects of these triPP-conjugates,
the most sensitive potentiometric approach was not possible to use because of the inevitable
interference with the tetraPP-sensitive electrode; therefore, we used a validated spectrofluorimetric
method with rhodamine 123, a cationic probe whose fluorescence increases following the
depolarization of mitochondria. All tested compounds produced a concentration-dependent
depolarization compared with that of isosteviol (Figure 2A,B). An interesting structure-activity
relationship was shown for compounds 1 and 5, which both have polymethylene linkers; in fact,
it is possible to correlate the depolarizing potency to the chain length connecting the isosteviol residue
to the triPP moiety. The most potent derivative was compound 5, which possesses the longest chain
and thus is probably the most lipophilic compound of the series (Figure 2C).
The accumulation of the most potent compounds 1 and 5 (Figure 2C and Table 1) in the
mitochondrial matrix was confirmed. This method revealed that compounds 1 and 5 were able
to completely enter into the matrix, even more effectively than tetraPP alone (Figure 3), which is
possibly due to the higher lipophilicity of these novel compounds than that of tetraPP.
Interestingly, in intact H9c2 cells, compound 5 was able to enter the mitochondrial matrix
in a time-dependent manner and effectively produced a “beneficial” depolarization of the ∆ψ in
living cells, which supports the protective role of this derivative in ischaemia-reperfusion insults.
Int. J. Mol. Sci. 2017, 18, 2060 8 of 13
Moreover, compound 5 entered the mitochondria at lower concentrations than that required by
isosteviol, based on the rationale by which the triPP-derivatives were synthetized.
However, the primary goal of this study is the development of innovative isosteviol-derived
compounds endowed with cardioprotective effects. In an in vivo model of acute myocardial infarct in
rats, isosteviol (ISO 500) showed significant cardioprotective effects, in good agreement with other
scientific papers reporting the use of this dose of isosteviol [12]. When tested at a 100-fold lower dose,
isosteviol did not show any significant cardioprotective effect. Instead, compound 5 at the equimolar
dose of ISO 5 produced a significant reduction in the size of the myocardial damage, similar to that
observed with higher dose of isosteviol (ISO 500), suggesting that the mitochondrial delivery ensured
by the triPP-strategy led to a significant improvement of the cardioprotective effects.
Further experiments are required to verify the cardioprotection offered by these innovative
compounds in myocardial I/R models, and their pharmacokinetic profile must be investigated to
verify their entry into the mitochondria after administration in vivo.
4. Materials and Methods
4.1. Substances
Sodium pentobarbital was purchased from Carlo Sessa in Milan, Italy. Isosteviol and the
triPP-derivatives (compounds 1–5; Figure 6) were synthesized according to the method reported
previously by Strobykina et al. [15], dissolved (10−2 M) in pure dimethyl sulfoxide (DMSO), and further
diluted in double-distilled water. Tetraphenylphosphonium chloride (tetraPP), rhodamine 123,
oligomycin, carbonyl cyanide m-chlorophenylhydrazone (CCCP), and valinomycin were purchased
from Sigma–Aldrich (St. Louis, MO, USA), dissolved in pure DMSO (100 mM), and further diluted in
double-distilled water.
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4. Materials and Methods 
4.1. Substances 
Sodium pentobarbital was purchased from Carlo Sessa in Milan, Italy. Isosteviol and the 
triPP-derivatives (compounds 1–5; Figure 6) were synthesized according to the method reported 
previously by Strobykina et al. [15], dissolved (10−2 M) in pure dimethyl sulfoxide (DMSO), and 
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Figure 6. Chemical structure of triphenylphosphonium (triPP)-conjugated derivatives of isosteviol. 
4.2. Experimental Procedures 
All experimental procedures were carried out following the guidelines of the European 
Community Council Directive 2010/63 and were approved by the Ethical Committee for animal 
experimentation of Pisa University (Protocol. N. 37321, 22 October 2013). All animals were housed 
(two per cage) in a room with controlled temperature (23–25 °C), humidity (50%), and lighting (12 h 
light/dark cycle) and provided with food and water ad libitum. On the day of experiment, male rats 
(300–400 g of body weight) were euthanized with an overdose of sodium pentobarbital (100 mg/kg, 
i.p.) and blood samples were collected. 
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4.2.1. Isolation Procedure of Mitochondria
Rat cardiac mitochondria were isolated by differential centrifugation according to the method of
Chappel and Hansford [22], as previously published [23].
Briefly, the heart was removed immediately and placed into ice cold isolation buffer (composition:
250 mM sucrose, 5 mM Tris, and 1 mM ethylene-bis(oxyethylenenitrilo)tetraacetic acid (EGTA, pH 7.4,
adjusted with HCl)). Atria were removed, and the ventricular tissues were finely minced with
surgical scissors (approximately 2 mm3 pieces) and homogenized using an Ultra-Turrax homogenizer
(20 mL of isolation buffer per heart).
Three homogenization cycles (20 s each) were performed on ice; then, the suspension was
centrifuged at 1075× g for 3 min at 4 ◦C. The resulting supernatant was again centrifuged at 11,950× g
for 10 min at 4 ◦C. The pellet, containing the mitochondrial fraction, was resuspended in isolation buffer
(without EGTA) and centrifuged at 11,950× g for 10 min at 4 ◦C; this step was repeated once more.
The final mitochondrial pellet was resuspended in a minimal volume of 400 µL of isolation buffer
(without EGTA). Mitochondria were stored on ice throughout processing and used within 2 h from
isolation. Mitochondrial protein concentrations were determined using the Bradford reaction [24,25].
Measurements of the Effects of Isosteviol on Mitochondrial Ca++ Uptake
Changes of the medium (i.e., extra-mitochondrial) Ca++ concentration were continuously
measured with a Ca++ selective mini-electrode coupled to a reference electrode (WPI, Worcester,
MA, USA) using data acquisition software (Biopac Inc., Goleta, CA, USA), as previously published [23].
The selectivity of the electrode for Ca++ over other cations, such as Mg2+, K+, and Na+, was >1 × 105.
Electrodes were calibrated before each experiment using known concentrations of CaCl2.
Mitochondria (1 mg protein/mL) were added to the incubation medium under gentle stirring
and treated with vehicle (DMSO 1%) or isosteviol (3, 10, or 30 µM). The maximal variation in the Ca++
concentration of the medium relative to its accumulation in the mitochondrial matrix was measured.
Each result was obtained with mitochondria isolated from the hearts of at least three different animals.
Measurement of Isosteviol Effects on Mitochondrial Membrane Potential
Potentiometric approach: Mitochondrial membrane potential (∆ψ) was potentiometrically
measured with tetraPP-sensitive mini-electrodes coupled to a reference electrode (WPI, Worcester, MA,
USA) using a data acquisition software (Biopac Inc.), as described in Calderone et al. [23].
Electrodes were calibrated before each experiment using known concentrations of tetraPP.
Mitochondria (1 mg protein/mL) were suspended in the incubation medium under gentle stirring
(composition: 120 mM KCl, 5 mM K2HPO4, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), 10 mM succinic acid, 2 mM MgCl2, and 1 mM EGTA (pH 7.4 adjusted with KOH)). The value
of the measured membrane potential was calculated according to the following Nernst-derived
experimental equation, as described in a previous paper [18].
∆ψ = 60× Log
V0· [TPP
+ ]0
[TPP+ ]t
−Vt − K0P
VmP + KiP
(1)
In the equation, the mitochondrial membrane potential (mV) is ∆ψ; V0 is the volume of the
incubation medium before the addition of mitochondria; Vt is the volume of the incubation medium
after the addition of mitochondria; Vm is the volume of the mitochondrial matrix (mg/mL protein);
[TPP+]0 and [TPP+]t are the concentrations of TPP+ before and after the addition of mitochondria at
time t, respectively; P is the protein concentration (mg); and K0 and Ki are the apparent external and
internal partition coefficients of TPP+, which were estimated as 14.3 and 7.9 mL/mg, respectively.
The concentration of mitochondria was 1 mg of protein/mL [26]. The volume of the mitochondrial
suspension was 1 mL.
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Changes in the ∆ψ were continuously recorded before and after the addition of cumulatively
increasing concentrations of isosteviol (range 0.1–30 µM) to the incubation medium.
Each concentration–response curve was obtained with mitochondria isolated from the hearts of at
least six different animals.
Spectrofluorimetric approach: The highly sensitive potentiometric approach could not be used
for testing the triPP-conjugates of isosteviol due to predicted interference with the tetraPP-sensitive
electrode; thus, another experimental method was used. Rhodamine 123 (5 µM) was added to the
mitochondrial (1 mg protein/mL) suspension incubation medium (composition: 120 mM KCl, 5 mM
K2HPO4, 10 mM HEPES, 10 mM succinic acid, 2 mM MgCl2, and 1 mM EGTA (pH 7.4 adjusted
with KOH)) under gentle stirring, and after a baseline recording, the mitochondria were treated with
isosteviol, triPP-derivatives (1–5), or vehicle (DMSO 1%).
The increase in fluorescence (due to the eventual depolarization induced by the tested compounds)
was monitored (λex = 490 nm, λem = 535 nm) with an EnSpire multiplate reader (PerkinElmer,
Waltham, MA, USA) for 6 min in the dark. Fluorescence values were expressed as the percentage of
fluorescence emitted by the rhodamine 123 solution (5 µM) normalized to the fluorescence without
mitochondria; the fluorescence value without mitochondria present was set at the maximum value
(100%). These experiments were completed within 1.5 h of the mitochondrial isolation step. Each result
was obtained with mitochondria isolated from the hearts of three to six different animals.
Measurement of triPP-Conjugated Isosteviol Derivative Entry into Mitochondrial Matrix
To verify the accumulation of triPP-conjugated compounds in the mitochondria, the original
approach using a tetraPP-sensitive electrode was employed. The addition of compounds 1 through 5
(5 µM) to the suspension buffer was potentiometrically recorded; the addition of mitochondria to the
buffer caused a decrease (measured as a reduction in the fluorescence signal) in the extra-mitochondrial
concentration of the isosteviol derivatives due to their uptake into the mitochondrial matrix.
The amount of loaded compound was quantified by measuring the signal deflection and was expressed
as a percentage of the value recorded before the addition of mitochondria.
4.2.2. H9c2 Cell Culture
H9c2 cells (ATTC, Manassas, VA, USA), a subclonal cell line from embryonic rat hearts, were
cultured in DMEM/F12 (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% of fetal bovine
serum (FBS, Sigma–Aldrich, St. Louis, MO, USA), 1.35 g/L glucose, 0.30 g/L sodium bicarbonate,
1 mM sodium pyruvate, 4 mM L-glutamine, 100 units/mL penicillin, and 100 units/mL streptomycin
and incubated at 37 ◦C in a humidified atmosphere of 5% CO2.
Analysis of ∆Ψ Changes on Intact H9c2 Cells
Changes in ∆ψ were assessed using the Muse MitoPotential Assay (MCH 100110, Merck Millipore;
Darmstadt, Germany), which enables the simultaneous measurement of live, depolarized,
depolarized/dead, and dead cells within the same sample. H9c2 cells were treated with DMSO
(0.3%, control sample), compound 5 (1 µM), or isosteviol (30 µM) for 2.5 or 5 h. The uncoupling agent
CCCP (30 µM) was used as a positive control. To perform the assay, cells were harvested, and the cell
pellets were suspended in assay buffer (105 cells/100 µL buffer). According to the manufacturer’s
instructions, the MitoPotential working solution was added, and the cell suspensions were incubated
at 37 ◦C for 20 min. After the addition of the Muse MitoPotential 7-AAD dye and incubation at room
temperature for 5 min, the variations in ∆Ψ were assessed by flow cytometry (Muse Cell Analyzer,
Merck Millipore; Darmstadt, Germany). The percentages of depolarized living and depolarized dead
cells were analyzed relative to the control and CCCP-treated cells.
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4.2.3. In Vivo Model of Acute Infarct of Myocardium
Male Wistar rats were divided into five groups (n = 6 in each group): a sham-operated
(SHAM) group and four I/R groups. The I/R groups included vehicle (VEHICLE, DMSO 0.1% v/v),
isosteviol 5 µg/Kg (ISO 5), isosteviol 500 µg/Kg (ISO 500), and compound 5 12.1 µg/Kg groups
(compound 5). This dose of compound 5 (12.1 µg/Kg) is equimolar to isosteviol 5 µg/Kg. Isosteviol
and compound 5 were dissolved in DMSO (100 mM) and then diluted in saline solution and injected
intravenously 10 min prior to occluding the left coronary artery.
The surgery was performed as previously described [18,23] with minor modifications.
Briefly, rats were anesthetized with an intra-peritoneal administration of sodium pentobarbital
(70 mg/kg). The trachea was cannulated and connected to a mechanical respiratory apparatus
(mod. 7025 Ugo Basile, Comerio, Italy) with a respiratory rate of 70 strokes/min (stroke volume,
1 mL/100 g body weight).
The chest was opened by a left thoracotomy, then a 6–0 surgical needle was passed 2 mm under
the left anterior descending coronary artery. A small plastic tube was placed in front of the coronary
artery, then the snare was pulled and fixed in place by clamping the tube with a hemostat, inducing a
local ischaemia in the myocardium for 30 min (ischaemic period). At the end of the ischaemic period,
the plastic tube was removed from the ligature and the artery was re-opened, allowing reperfusion
for 120 min (reperfusion period). During monitoring with an electrocardiographic analyzer (Mindray,
PM5000, 2 Biological Instruments, Varese, Italy), increases in T wave and ST segments were observed
in the ischaemic period; the ST segments returned to normal level during the reperfusion period.
After 120 min of reperfusion period, rats were euthanized by an overdose of pentobarbital sodium
and heart was removed, mounted on a Langendorff apparatus, and perfused for 10 min with Krebs
solution at 37 ◦C to wash out the coronary blood vessels. Then, the hearts were deprived of the
atria and right ventricle. The left ventricular tissue was dried, frozen at −20 ◦C for 50 min, cut into
2.0 mm sagittal sections, and immersed in 1% 2,3,5-triphenyltetrazolium chloride (TTC, Sigma-Aldrich)
solution at 37 ◦C for 20 min. Finally, the slices were fixed overnight in 10% formaldehyde and
the next day they were photographed. TTC reacts with NADH in the presence of dehydrogenase
enzymes to form a formazan derivative, which causes the staining of viable cells in an intense red color.
Red-stained viable tissue was easily distinguished from the infracted white-unstained necrotic tissue.
The infarct area (Ai) was planimetrically evaluated using an image analyzer program (The GIMP 2).
The infarct size was calculated as a percentage of the whole area of the left ventricle (Ai/ALV%).
4.3. Data Analysis
All data are expressed as the means ± standard error of the mean. Concentration response curves
were analyzed by nonlinear, fitting equations with computer software (GraphPad Prism 4.0, La Jolla,
CA, USA). Data were statistically analyzed by ANOVA, and p values less than 0.05 were considered
indicative of significant differences.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/10/2060/s1.
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